Provided by Tiger Fintech (Singapore) Pte. Ltd.

Titan Pharmaceuticals

4.45
-0.0250-0.56%
Post-market: 4.450.00000.00%19:33 EDT
Volume:3.61K
Turnover:16.03K
Market Cap:4.07M
PE:-0.97
High:4.54
Open:4.54
Low:4.35
Close:4.48
Loading ...
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2022

Major Issues Report

8-K - Current report
Jul 22, 2022

Major Issues Report

8-K - Current report
Jul 13, 2022

Major Issues Report

8-K - Current report
Jul 11, 2022

Major Issues Report

8-K - Current report
Jul 08, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 05, 2022

Major Issues Report

8-K - Current report
Jun 09, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 02, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2022

Major Issues Report

8-K - Current report
Apr 25, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Apr 04, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 31, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 31, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 28, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 25, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Feb 03, 2022

Major Issues Report

8-K - Current report